Pt Kimia Farma (Persero) Tbk - Fresh Graduate, Experienced Kimia Farma Janaury 2019

PT Kimia Farma (Persero) Tbk / kimiafarma.co.id

PT Kimia Farma (Persero) Tbk - Kimia Farma is a reliable public-listed pharmaceutical company in Indonesia which is majority owned by the Government of Indonesia. Kimia Farma is listed on the Indonesia Stock Exchange (IDX) under reference code KAEF. As today, Kimia Farma is 90.025% owned by the Government of Indonesia, 0.127% by management/employee and 9.848% by public. Based in Jakarta, Kimia Farma has its business activities focused in pharmaceutical manufacturing, pharmaceutical trade and distribution, retail pharmacy, health clinic, laboratories and optical clinics. Kimia Farma now has 7 production plant; Plant Jakarta, Plant Bandung, Plant Semarang, Plant Watudakon, Plant Garam Farmasi, Plant Medan, and lant Rapid Test. Kimia Farma also supported by 1 research and development office at Bandung and 1 central logistic unit Jakarta. Kimia Farma also supported 6 directly-owned subsidiaries and affiliated companies, namely PT Kimia Farma Trading & Distribution, PT Kimia Farma Apotek, PT Sinkona Indonesia Lestari, PT Kimia Farma Diagnostik, PT Kimia Farma Sungwun Pharmacopia and PT Asuransi InHealth Indonesia. As of the end of September 2018, Kimia Farma has 1,135 pharmacies, 530 health clinics, 55 clinical laboratories, and 10 optics throughout Indonesia.

In term of financial performance, Kimia Farma is running well in the third quarter of 2018 (3Q18, ended in 30 September 2018). According to information found in PT Kimia Farma (Persero) Tbk 2018 Third Quarter Report as quoted by JobsCDC.com, Kimia Farma registered total net revenue of Rp5.31 trillion (unaudited) as at the end of September 2018. This reflected an 23.37% increase year-on-year (YOY) as compared with Rp4.30 trillion (unaudited) in the same period previous year. Kimia Farma booked total profit of Rp483.29 billion in the third quarter of 2018 or 45.31% growth YOY as compared with Rp332.60 billion in the third quarter of 2017.

To support the business expansion and its organic growth, PT Kimia Farma (Persero) Tbk invites qualified candidates to fulfill the position as follows

Pharmacist for DAWAA (Saudi Arabia)
Major : Pharmacy, S2 Pharmacy.

Sales & Marketing
Major : D3/S1 any major, experience in the healthcare laboratory field prioritized.

Engineering & Production
Major : D3/S1 Civil Engineering, D3 Electromedics, D3 Electrical Engineering.

Information Technology
Major : D3/S1 Information System, D3/S1 Information Management.

Property
Major : S1 Civil Engineering, S1 Architect. Experience in the related field prioritized.

Business Development
Major : S1 Architect, S1 Civil Engineering.

Marcks' Venus Aesthetic Clinic
Major : Pharmacy, Ners and Senior High School (Therapist)
  
Pharmacist
Major : Pharmacy.

Clinical Laboratory
Major : D3/D4 Health Analyst (have STR is a must), Ners, D3 Radiographer. Experience in the healthcare laboratory field prioritized.

Secretary of the Board of Directors
Major : D3 Secretary, D3 Commerce Administration, D3 English, D3 Business Administration.

Frontliner
Major : D3/S1 any major.

Legal Officer
Major : S1 Law.
General Requirements

• D3 in any related major (maximum age of 26 years old).
• S1 in any related major (maximum age of 27 years old).
• Have experience in the same field is an advantage.
• Minimum GPA of 3.00 (scale 4.00).
• Minimum Accreditation B for Perguruan Tinggi Negeri (all major).
• Minimum Accreditation A for Perguruan Tinggi Swasta (all major).
• Fresh graduate are welcome to apply.
• Energetic, hard worker, high integrity and well groomed.
• Single/not married.

For further information, please refer official source from PT Kimia Farma (Persero) Tbk on following link below. If you match the profile and are interested in this exiting career opportunity, please apply in confidence by filling online application form at https://bit.ly/jobfairkaefjan (Your application will go directly to Kimia Farma). Online submission deadline 24 January 2019. Application will be treated strictly confidential and only short-listed candidates will receive responses. (JobsCDC.com / Source)

Sumber http://www.jobscdc.com/